Market Cap 6.85B
Revenue (ttm) 5.29B
Net Income (ttm) 191.54M
EPS (ttm) N/A
PE Ratio 27.71
Forward PE 19.38
Profit Margin 3.62%
Debt to Equity Ratio 0.28
Volume 1,274,600
Avg Vol 940,050
Day's Range N/A - N/A
Shares Out 158.27M
Stochastic %K 79%
Beta -0.08
Analysts Strong Sell
Price Target $50.83

Company Profile

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. It also provides senior care and independent living facilities. The company engages in the acquisition, ownership, and leasing of health care-related properties. PACS Group, Inc. was founded in 2013 and is headquartered in Salt Lake City, Utah.

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 801 447 9829
Website: pacs.com
Address:
90 S. 400 W, Suite 700, Salt Lake City, United States
CosmicMiner
CosmicMiner Jul. 14 at 8:58 PM
$PACS Breakout looks clean. Price is showing strong momentum after clearing resistance. The key now is whether buyers can defend the breakout zone. Holding above the breakout level with volume would confirm continuation, while a failed retest could bring a pullback. Momentum is starting to build. The next opportunity may come sooner than expected.
0 · Reply
Smokesdrugs
Smokesdrugs Jul. 13 at 3:41 PM
$PACS wonder how long mark will continue selling
0 · Reply
parcha
parcha Jul. 11 at 10:40 PM
https://youtube.com/watch?v=XcJytsCutVs&is=yYIObTMWkUPuq9xs $DAVE $SNEX $PACS $BTSG 1. Dave Inc. (DAVE): A consumer finance name showing a strong uptrend and base breakout. Dave notes it is currently overbought, suggesting a potential tactical pullback (6:51-9:48). 2. StoneX Group (SNEX): An investment banking and brokerage firm. Its chart shows a recent run-up and pullback to the 50-day moving average, offering a potential entry point (9:49-12:04). 3. PACS Group (PACS): A healthcare facility operator currently experiencing a "big base breakout" after a period of sideways consolidation in 2026 (12:05-17:04). 4. BrightSpring Health Services (BTSG): Highlighted as a textbook example of a consistent, long-term uptrend (17:05-19:34). 5. MYR Group (MYR): An industrial stock currently in a consolidation phase, where Dave recommends waiting for a clear breakout above $480 for confirmation (19:35-22:14).
0 · Reply
DrabCrab5
DrabCrab5 Jul. 6 at 3:01 PM
$PACS Just got access to a batch of equity research reports covering the Eduro acquisition. Only UBS includes insights from mgmt who they spoke with (summarized below). - Facilities are higher performing than a typical PACS acquisition (occupancy, skilled mix, etc.) and are expected to have day 1 EBITDA contribution - Despite not being a typical distressed / underperforming asset acquisition, facilities still have room for operational improvement - Deal was under discussion for quite some time due to long time relationship between PACS mgmt and seller - Despite now being well above "target" facility acquisitions for the year, mgmt fully expects to complete additional facility acquisitions in 2026 and reiterated their pipeline remains healthy - PACS plans to provide additional details about the acquisition during its Q2 earnings call
0 · Reply
DrabCrab5
DrabCrab5 Jul. 1 at 3:16 PM
$PACS new intraday all time high! If we close above $42.94 that will also be an all time high close.
1 · Reply
Doozio
Doozio Jun. 30 at 9:49 PM
After da MNDY 🐑 $PACS man $EAT s those huckleberries thru da $$$
1 · Reply
MaverikIT
MaverikIT Jun. 30 at 7:38 PM
@Jblack500 @cynicaloptimist @BustaCapital @IsabellaDC @WAJeff @No_Face_character $PACS
4 · Reply
DrabCrab5
DrabCrab5 Jun. 30 at 4:13 PM
$PACS new 52-week high.
0 · Reply
DrabCrab5
DrabCrab5 Jun. 29 at 8:42 PM
$PACS it felt like this was coming given lack of deals YTD and what they’ve pubclicly communicated about their pipeline, looking at chunkier deals, etc. While I generally speaking am supportive of this strategy, I see no information on purchase price, EBITDA, the deal being accretive / dilutive, and so on. Perhaps there will be a presentation released… it would feel odd to leave the market hanging on what is a material deal for them.
0 · Reply
Smokesdrugs
Smokesdrugs Jun. 29 at 8:34 PM
$PACS big acquisition
0 · Reply
Latest News on PACS
Pacs Group price target raised to $57 from $50 at UBS

2026-07-08T12:56:50.000Z - 6 days ago

Pacs Group price target raised to $57 from $50 at UBS


PACS Group Transcript: AGM 2026

Jun 10, 2026, 1:00 PM EDT - 4 weeks ago

PACS Group Transcript: AGM 2026


Pacs Group price target raised to $52 from $50 at Truist

2026-05-18T12:18:22.000Z - 2 months ago

Pacs Group price target raised to $52 from $50 at Truist


Pacs Group price target raised to $48 from $42 at Oppenheimer

2026-05-13T11:58:22.000Z - 2 months ago

Pacs Group price target raised to $48 from $42 at Oppenheimer


Pacs Group rises 24.1%

2026-05-12T19:03:01.000Z - 2 months ago

Pacs Group rises 24.1%


Pacs Group rises 20.5%

2026-05-12T17:57:17.000Z - 2 months ago

Pacs Group rises 20.5%


PACS Group Earnings Call Transcript: Q1 2026

May 12, 2026, 11:30 AM EDT - 2 months ago

PACS Group Earnings Call Transcript: Q1 2026


PACS Group Quarterly report: Q1 2026

May 12, 2026, 11:30 AM EDT - 2 months ago

PACS Group Quarterly report: Q1 2026


PACS Group Earnings release: Q1 2026

May 12, 2026, 11:30 AM EDT - 2 months ago

PACS Group Earnings release: Q1 2026


PACS Group Slides: Q1 2026

May 12, 2026, 11:30 AM EDT - 2 months ago

PACS Group Slides: Q1 2026


Pacs Group  reports Q1 EPS 50c, consensus 41c

2026-05-11T23:51:37.000Z - 2 months ago

Pacs Group reports Q1 EPS 50c, consensus 41c


PACS Group, Inc. Reports First Quarter 2026 Results

May 11, 2026, 4:30 PM EDT - 2 months ago

PACS Group, Inc. Reports First Quarter 2026 Results


PACS Group Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

PACS Group Proxy statement: Proxy filing


PACS Group Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

PACS Group Proxy statement: Proxy filing


Pacs Group co-founder, CFO Mark Hancock to retire

2026-04-27T20:42:55.000Z - 2 months ago

Pacs Group co-founder, CFO Mark Hancock to retire


Pacs Group names Carey Hendrickson CFO

2026-04-27T20:42:37.000Z - 2 months ago

Pacs Group names Carey Hendrickson CFO


Pacs Group price target raised to $42 from $40 at Oppenheimer

2026-03-04T12:53:06.000Z - 4 months ago

Pacs Group price target raised to $42 from $40 at Oppenheimer


Pacs Group price target raised to $44 from $42 at UBS

2026-03-04T12:45:08.000Z - 4 months ago

Pacs Group price target raised to $44 from $42 at UBS


Pacs Group price target raised to $52 from $47 at RBC Capital

2026-02-27T14:57:17.000Z - 4 months ago

Pacs Group price target raised to $52 from $47 at RBC Capital


PACS Group Earnings Call Transcript: Q4 2025

Feb 26, 2026, 5:30 PM EST - 4 months ago

PACS Group Earnings Call Transcript: Q4 2025


PACS Group Annual report: Q4 2025

Feb 26, 2026, 5:30 PM EST - 4 months ago

PACS Group Annual report: Q4 2025


PACS Group Earnings release: Q4 2025

Feb 26, 2026, 5:30 PM EST - 4 months ago

PACS Group Earnings release: Q4 2025


PACS Group Slides: Q4 2025

Feb 26, 2026, 5:30 PM EST - 4 months ago

PACS Group Slides: Q4 2025


Pacs Group reports Q4 adjusted EBITDA $142.1M

2026-02-26T22:03:19.000Z - 4 months ago

Pacs Group reports Q4 adjusted EBITDA $142.1M


PACS Group Inc call buyer realizes 7% same-day gains

2026-02-18T13:00:20.000Z - 5 months ago

PACS Group Inc call buyer realizes 7% same-day gains


Pacs Group price target lowered to $40 from $48 at Truist

2026-01-05T12:26:30.000Z - 6 months ago

Pacs Group price target lowered to $40 from $48 at Truist


PACS Group Announces Business Updates

Dec 1, 2025, 4:15 PM EST - 8 months ago

PACS Group Announces Business Updates


PACS Group Proxy statement: Proxy Filing

Nov 25, 2025, 7:00 AM EST - 8 months ago

PACS Group Proxy statement: Proxy Filing


PACS Group Earnings Call Transcript: Q3 2025

Nov 19, 2025, 5:30 PM EST - 8 months ago

PACS Group Earnings Call Transcript: Q3 2025


PACS Group Earnings release: Q3 2025

Nov 19, 2025, 5:30 PM EST - 8 months ago

PACS Group Earnings release: Q3 2025


PACS Group Quarterly report: Q3 2025

Nov 19, 2025, 5:30 PM EST - 8 months ago

PACS Group Quarterly report: Q3 2025


PACS Group Slides: Q3 2025

Nov 19, 2025, 5:30 PM EST - 8 months ago

PACS Group Slides: Q3 2025


PACS Group, Inc. Reports Third Quarter 2025 Results

Nov 19, 2025, 4:30 PM EST - 8 months ago

PACS Group, Inc. Reports Third Quarter 2025 Results


PACS Group Annual report: Q4 2024

Mar 28, 2025, 8:00 AM EDT - 1 year ago

PACS Group Annual report: Q4 2024


CosmicMiner
CosmicMiner Jul. 14 at 8:58 PM
$PACS Breakout looks clean. Price is showing strong momentum after clearing resistance. The key now is whether buyers can defend the breakout zone. Holding above the breakout level with volume would confirm continuation, while a failed retest could bring a pullback. Momentum is starting to build. The next opportunity may come sooner than expected.
0 · Reply
Smokesdrugs
Smokesdrugs Jul. 13 at 3:41 PM
$PACS wonder how long mark will continue selling
0 · Reply
parcha
parcha Jul. 11 at 10:40 PM
https://youtube.com/watch?v=XcJytsCutVs&is=yYIObTMWkUPuq9xs $DAVE $SNEX $PACS $BTSG 1. Dave Inc. (DAVE): A consumer finance name showing a strong uptrend and base breakout. Dave notes it is currently overbought, suggesting a potential tactical pullback (6:51-9:48). 2. StoneX Group (SNEX): An investment banking and brokerage firm. Its chart shows a recent run-up and pullback to the 50-day moving average, offering a potential entry point (9:49-12:04). 3. PACS Group (PACS): A healthcare facility operator currently experiencing a "big base breakout" after a period of sideways consolidation in 2026 (12:05-17:04). 4. BrightSpring Health Services (BTSG): Highlighted as a textbook example of a consistent, long-term uptrend (17:05-19:34). 5. MYR Group (MYR): An industrial stock currently in a consolidation phase, where Dave recommends waiting for a clear breakout above $480 for confirmation (19:35-22:14).
0 · Reply
DrabCrab5
DrabCrab5 Jul. 6 at 3:01 PM
$PACS Just got access to a batch of equity research reports covering the Eduro acquisition. Only UBS includes insights from mgmt who they spoke with (summarized below). - Facilities are higher performing than a typical PACS acquisition (occupancy, skilled mix, etc.) and are expected to have day 1 EBITDA contribution - Despite not being a typical distressed / underperforming asset acquisition, facilities still have room for operational improvement - Deal was under discussion for quite some time due to long time relationship between PACS mgmt and seller - Despite now being well above "target" facility acquisitions for the year, mgmt fully expects to complete additional facility acquisitions in 2026 and reiterated their pipeline remains healthy - PACS plans to provide additional details about the acquisition during its Q2 earnings call
0 · Reply
DrabCrab5
DrabCrab5 Jul. 1 at 3:16 PM
$PACS new intraday all time high! If we close above $42.94 that will also be an all time high close.
1 · Reply
Doozio
Doozio Jun. 30 at 9:49 PM
After da MNDY 🐑 $PACS man $EAT s those huckleberries thru da $$$
1 · Reply
MaverikIT
MaverikIT Jun. 30 at 7:38 PM
@Jblack500 @cynicaloptimist @BustaCapital @IsabellaDC @WAJeff @No_Face_character $PACS
4 · Reply
DrabCrab5
DrabCrab5 Jun. 30 at 4:13 PM
$PACS new 52-week high.
0 · Reply
DrabCrab5
DrabCrab5 Jun. 29 at 8:42 PM
$PACS it felt like this was coming given lack of deals YTD and what they’ve pubclicly communicated about their pipeline, looking at chunkier deals, etc. While I generally speaking am supportive of this strategy, I see no information on purchase price, EBITDA, the deal being accretive / dilutive, and so on. Perhaps there will be a presentation released… it would feel odd to leave the market hanging on what is a material deal for them.
0 · Reply
Smokesdrugs
Smokesdrugs Jun. 29 at 8:34 PM
$PACS big acquisition
0 · Reply
DrabCrab5
DrabCrab5 Jun. 29 at 2:08 PM
$PACS ~2% off 52-week high and ~4% off ATH.
1 · Reply
Shlobby
Shlobby Jun. 26 at 10:53 PM
$PACS this looks ready too
0 · Reply
Smokesdrugs
Smokesdrugs Jun. 26 at 5:41 PM
$PACS cmon mark stop selling
1 · Reply
Smokesdrugs
Smokesdrugs Jun. 25 at 3:02 PM
$PACS finally behaving like a solid stock
1 · Reply
ReigningTrades
ReigningTrades Jun. 25 at 3:31 AM
$PACS important few weeks coming up to see if we get some upside follow through. Would not mind an initial rejection in the 41-42 range but would like to see buyers absorbing and sellers defense weakening. Should be a picture-perfect cup & handle breakout by the time the leaves start falling!
0 · Reply
Doozio
Doozio Jun. 24 at 3:25 PM
$PACS $WEN ? ONTO 🐒🍌🧠⏰♾️
0 · Reply
DrabCrab5
DrabCrab5 Jun. 24 at 2:05 PM
$PACS Two solid updates: - JPM updated their model on 6/15 and increased their price target to $47 ($44 previously) - Ohio approved $875M in retroactive quality incentive payments for skilled nursing homes following a determination that they underpaid previous quality incentive payments. As of Q1, PACS operates nearly 8% of the states total SNF beds which means they should receive a nice make whole payment.
0 · Reply
Smokesdrugs
Smokesdrugs Jun. 22 at 7:52 PM
$PACS just needs to move like this more often and it’ll be in the $50+ range where it should be in no time.
0 · Reply
Doozio
Doozio Jun. 19 at 3:04 PM
$PACS chop chop huckleberries as rotation out of semis n AI stonks (which start to consolidate) find da proper bases on the DLO ONTO 🐒🍌🧠⏰♾️
0 · Reply
Doozio
Doozio Jun. 19 at 2:48 PM
$PACS out of the tightness da 🧠 shall spread like its staying at da $ABNB ONTO 🐒🍌🧠⏰♾️
1 · Reply
DrabCrab5
DrabCrab5 Jun. 18 at 2:57 PM
$PACS another wrinkle to this name. Mark Hancock, one of the company’s co-founders, now has a 10b5-1 plan established to sell shares. This should not come as a huge surprise given his re-retirement after filling in as stop gap CFO, as well as his massive position (~54.5m shares owned). A reduction in his ownership and increased trading liquidity should be a good thing long term, but hard to say what kind of overhang (if any) this will be. I obviously have no idea what his planning situation looks like, how many shares he wants to hold on to, etc. but without a large secondary offering, it will take him multiple years to exit his full position given the average trading volume for PACS.
1 · Reply
DrabCrab5
DrabCrab5 Jun. 18 at 2:47 PM
$PACS with only 4 SNF acquisitions completed year to date, PACS is now lagging its target of ~20 per year. Given what they have communicated about the health of their M&A pipeline, I do wonder if they are working on a chunky deal. The balance sheet is clean (net leverage is below 0.5x), they have nearly $800M in available liquidity, and will continue to generate cash as we progress through the year. One would also imagine the government investigation will come to a close at some point. The government inquiry was technically opened back in November of 2024, and PACS gave the government the findings from its own internal investigation back in November of 2025.
1 · Reply